Literature DB >> 10049751

Actin polymerization induces shedding of FcgammaRIIIb (CD16) from human neutrophils.

P J Middelhoven1, J D van Buul, M Kleijer, D Roos, P L Hordijk.   

Abstract

FcgammaRIIIb (CD16) is a glycosyl phosphatidylinositol (GPI)-anchored low-affinity IgG receptor, exclusively expressed on human neutrophils. FcgammaRIIIb associates with complement receptor 3 (CR3, Mac-1, CD11b/CD18), which may indirectly link FcgammaRIIIb to the actin cytoskeleton. Upon neutrophil activation, apoptosis, or chemotaxis, FcgammaRIIIb is shed from the cell surface. In all of these events, actin rearrangements play an important role. To establish a role for the actin cytoskeleton in the control of FcgammaRIIIb shedding, we treated human neutrophils with jasplakinolide, an actin-polymerizing peptide. We show that enhanced actin polymerization induces time- and dose-dependent shedding of FcgammaRIIIb. This effect was not restricted to FcgammaRIIIb, because the cell surface expression of CD43, CD44, and L-selectin was also downregulated after induction of actin polymerization. This actin-dependent pathway is staurosporine sensitive but does not appear to involve activation of PKC or CR3. These data show that the actin cytoskeleton can regulate protein ectodomain shedding from human neutrophils. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049751     DOI: 10.1006/bbrc.1999.0244

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Different proteolytic mechanisms involved in Fc gamma RIIIb shedding from human neutrophils.

Authors:  P J Middelhoven; J D Van Buul; P L Hordijk; D Roos
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

2.  Tolerance of glycosylphosphatidylinositol (GPI)-specific phospholipase D overexpression by Chinese hamster ovary cell mutants with aberrant GPI biosynthesis.

Authors:  Xiaohan Du; Jiewei Cai; Jian-zhong Zhou; Victoria L Stevens; Martin G Low
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

3.  ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis.

Authors:  Yue Wang; Adam C Zhang; Zhenya Ni; Amy Herrera; Bruce Walcheck
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

4.  Sulphatides trigger polymorphonuclear granulocyte spreading on collagen-coated surfaces and inhibit subsequent activation of 5-lipoxygenase.

Authors:  G F Sud'ina; T G Brock; M A Pushkareva; S I Galkina; D V Turutin; M Peters-Golden; V Ullrich
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

5.  An Allosteric Shift in CD11c Affinity Activates a Proatherogenic State in Arrested Intermediate Monocytes.

Authors:  Alfredo A Hernandez; Greg A Foster; Stephanie R Soderberg; Andrea Fernandez; Mack B Reynolds; Mable K Orser; Keith A Bailey; Jason H Rogers; Gagan D Singh; Huaizhu Wu; Anthony G Passerini; Scott I Simon
Journal:  J Immunol       Date:  2020-10-14       Impact factor: 5.422

6.  Oxidant alterations in CD16 expression are cytoskeletal induced.

Authors:  Joseph Cuschieri; Sana Sakr; Eileen Bulger; Megan Knoll; Saman Arbabi; Ronald V Maier
Journal:  Shock       Date:  2009-12       Impact factor: 3.454

7.  Activation of human neutrophils by the anti-inflammatory mediator Esenbeckia leiocarpa leads to atypical apoptosis.

Authors:  Rafael de Liz; Heros Horst; Moacir Geraldo Pizzolatti; Tânia Silvia Fröde; Denis Girard
Journal:  Mediators Inflamm       Date:  2012-05-08       Impact factor: 4.711

8.  A cryo-electron tomography workflow reveals protrusion-mediated shedding on injured plasma membrane.

Authors:  Shrawan Kumar Mageswaran; Wei Yuan Yang; Yogaditya Chakrabarty; Catherine M Oikonomou; Grant J Jensen
Journal:  Sci Adv       Date:  2021-03-26       Impact factor: 14.136

Review 9.  Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance.

Authors:  Charita Furumaya; Paula Martinez-Sanz; Panagiota Bouti; Taco W Kuijpers; Hanke L Matlung
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.